Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
about
Kidney xenotransplantationControlling coagulation dysregulation in xenotransplantation.Overcoming the barriers to xenotransplantation: prospects for the futureRapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healingHuman immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs.Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cellsComparative N-linked glycan analysis of wild-type and α1,3-galactosyltransferase gene knock-out pig fibroblasts using mass spectrometry approachesUsing an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40.Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs.Allorecognition and the alloresponse: clinical implications.Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.The effect of Gal expression on pig cells on the human T-cell xenoresponse.Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.Complement activation and coagulation in xenotransplantation.Structural biology of carbohydrate xenoantigens.Rat-to-Chinese tree shrew heart transplantation is a novel small animal model to study non-Gal-mediated discordant xenograft humoral rejection.Immunological challenges and therapies in xenotransplantation.Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.The immunological barriers to xenotransplantation.The pathobiology of pig-to-primate xenotransplantation: a historical review.Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds.Decellularized GGTA1-KO pig heart valves do not bind preformed human xenoantibodies.Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons.The impact of serum incubation time on IgM/IgG binding to porcine aortic endothelial cells.The Role of NK Cells in Pig-to-Human Xenotransplantation.A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity.
P2860
Q26822638-35565C0F-A74F-4258-A6C7-3B98F4E8F838Q33394542-4766446D-A731-452B-9545-5B96AA5E5841Q33801035-3692D301-8E28-49D5-AF67-F7C66C773DF6Q33881766-6611476E-CA5E-470B-83DF-0D80A6BAF70CQ34213417-16825D6A-8E25-4E34-BA88-941BABBC2546Q34674677-42BF28F5-A6DE-4AB0-8A49-5FAE1371DDB6Q35039006-9FCC8809-B91F-4A9F-936F-931D6BF50344Q36668896-CCD4032A-0F05-4667-905C-BE16F759AEB3Q36734731-916EB288-DE97-4C2F-B60C-B4B6A4EA3346Q36820105-5FE00056-CD8D-4526-AE16-4372506503F1Q37058688-3C16D705-58A9-4B4C-B320-4C7B67441DD0Q37163584-ED1458FA-D53C-4F40-9A44-855540A827F9Q37361071-4E43902A-8D5D-45B6-A6EE-94B8DE0574C3Q37372498-B5D5C37D-AE92-45C4-9DDA-AA6F24C16F62Q37547263-2E776287-02F0-4C44-90B4-66E32ED40615Q37600806-182F28E1-2C1F-46B9-849E-FE84ED3FEB40Q37670770-AD501A0F-1F17-476B-A8AF-88204CB6F842Q37919109-94D0D2B4-1C39-4E76-805B-864C3E7C3CBAQ38191251-04A061F2-FFB2-4DCB-8461-BAEB059CF11AQ38298848-636C421D-BACF-489D-A7E3-1A919439A22CQ38299403-B51BCFED-BC98-4B4C-BC4E-F354D4F90B96Q38588520-107607AA-C1C6-40F2-94D2-CAE400EABA21Q38712532-E258D605-FEB9-40AE-8FA6-EEBD2B1B442EQ39782408-DD280AD6-D8A4-42C2-9860-9F742FE7D9CEQ39787176-45B62EEE-FF86-4E53-A40A-C07FC094654EQ39985919-875CF24C-0FED-4FB2-8739-DF52F644D2DBQ41846160-A34EE494-A81A-4B90-89C2-8ADCD1AFB076Q48088290-4A97219E-AD4E-41A3-ABC3-891C5166DA3BQ48093746-5DDA2CB5-A451-4C87-894E-69B98C54E982Q53971248-7AE3F8BE-0223-4565-A736-8318F0A332AE
P2860
Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reactivity of human natural an ...... lalpha(1,3)Gal-deficient pigs.
@en
type
label
Reactivity of human natural an ...... lalpha(1,3)Gal-deficient pigs.
@en
prefLabel
Reactivity of human natural an ...... lalpha(1,3)Gal-deficient pigs.
@en
P2093
P1433
P1476
Reactivity of human natural an ...... lalpha(1,3)Gal-deficient pigs.
@en
P2093
Bettina C Baumann
Georg Stussi
Jörg D Seebach
Katja Huggel
Robert Rieben
P304
P356
10.1097/01.TP.0000250478.00567.E5
P577
2007-01-01T00:00:00Z